$ONVO
ORGANOVO HOLDINGS, INC.

2016 Q4 Form 10-Q Financial Statement

#000156459016027345 Filed on November 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2016 Q1
Revenue $1.151M $1.376M $548.0K
YoY Change 250.91% 357.14% 105.24%
Cost Of Revenue $210.0K $393.0K
YoY Change
Gross Profit $940.0K $983.0K
YoY Change
Gross Profit Margin 81.67% 71.44%
Selling, General & Admin $5.550M $5.920M $4.440M
YoY Change -10.63% -13.58% -3.48%
% of Gross Profit 590.43% 602.24%
Research & Development $5.020M $4.540M $4.540M
YoY Change 9.37% -4.22% 24.73%
% of Gross Profit 534.04% 461.85%
Depreciation & Amortization $320.0K $250.0K $260.0K
YoY Change 33.33% 38.89% 85.71%
% of Gross Profit 34.04% 25.43%
Operating Expenses $10.57M $10.47M $8.980M
YoY Change -2.13% -9.66% 8.98%
Operating Profit -$9.630M -$9.479M
YoY Change -16.0%
Interest Expense $50.00K $40.00K $60.00K
YoY Change 150.0% 33.33% -66.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$9.580M -$9.440M -$8.370M
YoY Change -8.41% -16.16% 7.31%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.581M -$9.442M -$8.372M
YoY Change -8.36% -16.12% 7.36%
Net Earnings / Revenue -832.41% -686.19% -1527.74%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.893M -$2.026M -$1.856M
COMMON SHARES
Basic Shares Outstanding 103.9M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.00M $51.72M $62.09M
YoY Change -0.04% -32.71% 23.83%
Cash & Equivalents $70.00M $51.72M $62.09M
Short-Term Investments
Other Short-Term Assets $590.0K $910.0K $970.0K
YoY Change 22.92% 28.17% -7.62%
Inventory $330.0K $445.0K $334.0K
Prepaid Expenses
Receivables $1.030M $606.0K $259.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $71.94M $53.68M $63.65M
YoY Change 1.68% -31.03% 24.17%
LONG-TERM ASSETS
Property, Plant & Equipment $3.940M $3.647M $3.711M
YoY Change 10.67% 0.47% 81.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $250.0K $128.0K $134.0K
YoY Change 8.7% -41.82% 26.42%
Total Long-Term Assets $4.190M $3.854M $3.924M
YoY Change 10.55% 0.1% 76.2%
TOTAL ASSETS
Total Short-Term Assets $71.94M $53.68M $63.65M
Total Long-Term Assets $4.190M $3.854M $3.924M
Total Assets $76.13M $57.54M $67.58M
YoY Change 2.13% -29.56% 26.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $720.0K $754.0K $787.0K
YoY Change 53.19% 32.28% -43.26%
Accrued Expenses $3.090M $2.831M $2.450M
YoY Change -13.45% -19.8% 8.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $4.440M $4.220M $4.490M
YoY Change -19.27% -23.55% -5.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $790.0K $830.0K $910.0K
YoY Change 8200.0% 2933.33%
Total Long-Term Liabilities $790.0K $830.0K $910.0K
YoY Change 8200.0% 2933.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.440M $4.220M $4.490M
Total Long-Term Liabilities $790.0K $830.0K $910.0K
Total Liabilities $5.230M $5.050M $5.395M
YoY Change -4.91% -8.6% 12.56%
SHAREHOLDERS EQUITY
Retained Earnings -$179.1M -$160.9M
YoY Change 26.07% 31.54%
Common Stock $223.1M
YoY Change 30.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $70.90M $52.49M $62.18M
YoY Change
Total Liabilities & Shareholders Equity $76.13M $57.54M $67.58M
YoY Change 2.13% -29.56% 26.34%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2016 Q1
OPERATING ACTIVITIES
Net Income -$9.581M -$9.442M -$8.372M
YoY Change -8.36% -16.12% 7.36%
Depreciation, Depletion And Amortization $320.0K $250.0K $260.0K
YoY Change 33.33% 38.89% 85.71%
Cash From Operating Activities -$7.050M -$6.370M -$7.530M
YoY Change 1.88% -26.1% 34.22%
INVESTING ACTIVITIES
Capital Expenditures -$610.0K -$440.0K -$400.0K
YoY Change 281.25% -2.22% -38.46%
Acquisitions
YoY Change
Other Investing Activities -$50.00K $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$660.0K -$440.0K -$410.0K
YoY Change 312.5% 2.33% -36.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.98M 5.000M 0.000
YoY Change 10725.0% -6350.0% -100.0%
NET CHANGE
Cash From Operating Activities -7.050M -6.370M -7.530M
Cash From Investing Activities -660.0K -440.0K -410.0K
Cash From Financing Activities 25.98M 5.000M 0.000
Net Change In Cash 18.27M -1.810M -7.940M
YoY Change -367.11% -80.18% -7318.18%
FREE CASH FLOW
Cash From Operating Activities -$7.050M -$6.370M -$7.530M
Capital Expenditures -$610.0K -$440.0K -$400.0K
Free Cash Flow -$6.440M -$5.930M -$7.130M
YoY Change -4.73% -27.42% 43.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-21000
us-gaap Net Income Loss
NetIncomeLoss
-18209000
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160870000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1150000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14921000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1550000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-452000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
4500000
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
ONVO
dei Entity Registrant Name
EntityRegistrantName
ORGANOVO HOLDINGS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001497253
CY2016Q3 onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
345000
CY2015Q3 onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
19000
onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
557000
onvo Revenue From Research Collaborations
RevenueFromResearchCollaborations
33000
CY2016Q3 us-gaap Revenue From Grants
RevenueFromGrants
8000
CY2015Q3 us-gaap Revenue From Grants
RevenueFromGrants
95000
us-gaap Revenue From Grants
RevenueFromGrants
12000
onvo Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-68000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
452000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
14000
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93750862
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57536000
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93750862
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
52487000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
62181000
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
92391989
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67576000
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
92391989
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11468000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
11585000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11257000
us-gaap Net Income Loss
NetIncomeLoss
-19748000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62091000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10974000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8881000
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
259000
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4490000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
92385150
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
93185400
us-gaap Costs And Expenses
CostsAndExpenses
20349000
CY2016Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
147000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000
CY2016Q3 us-gaap Assets
Assets
57536000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
754000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
103865862
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
606000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
479000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q3 us-gaap Inventory Net
InventoryNet
445000
CY2016Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179079000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-7000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2831000
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
829000
CY2016Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
905000
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
0
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
92790850
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11284000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
180000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87715217
us-gaap Operating Income Loss
OperatingIncomeLoss
-18256000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19742000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9479000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-5000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
28000
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
393000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-33000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-820000
us-gaap Share Based Compensation
ShareBasedCompensation
3522000
us-gaap Costs And Expenses
CostsAndExpenses
20522000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9449000
CY2016Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0
CY2016Q3 us-gaap Revenues
Revenues
1376000
CY2015Q3 us-gaap Revenues
Revenues
301000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
502000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
1023000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
324000
CY2015Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
9000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-11257000
us-gaap Share Based Compensation
ShareBasedCompensation
3952000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-28000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
381000
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
111000
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
0
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
164000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
187000
us-gaap Sales Revenue Net
SalesRevenueNet
1697000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
314000
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
-105000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
347000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-80000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-337000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
908000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
53682000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3647000
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
79000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
35000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1571000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
43137000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
81000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5000000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10368000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50142000
us-gaap Interest Paid
InterestPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
22000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-631000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14909000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
605000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
549000
CY2016Q3 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2015Q1 onvo Lease Rental Period Start Date
LeaseRentalPeriodStartDate
2015-02-01
CY2015Q1 onvo Lease Rental Period End Date
LeaseRentalPeriodEndDate
2018-01-31
CY2015Q1 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
12000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
500000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
0
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
5000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
43213000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26721000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76863000
us-gaap Interest Paid
InterestPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
138000
onvo Leasehold Improvements Funded By Lease Incentive
LeaseholdImprovementsFundedByLeaseIncentive
374000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets. </p></div>
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue arrangements with multiple deliverables </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company follows ASC 605-25 <font style="font-style:italic;">Revenue Recognition &#8211; Multiple-Element Arrangements</font> for revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (&#8220;VSOE&#8221;) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#8217;s results of operations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically receives license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value. </p></div>
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Product revenue </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. To date, the Company has not recognized significant revenue from commercial product sales.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As our commercial sales increase, we expect to establish a reserve for estimated product returns that will be recorded as a reduction to revenue. This reserve will be maintained to account for future return of products sold in the current period. The reserve will be reviewed quarterly and will be estimated based on an analysis of our historical experience related to product returns.</p></div>
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2015Q3 us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13200000
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10500000
CY2011 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2012 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2015Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9000
CY2016Q3 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
0
CY2015Q3 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
0
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
0
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
38234
CY2016Q3 onvo Deregistered Common Stock Value
DeregisteredCommonStockValue
26777784
CY2016Q3 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
123104
CY2015Q3 onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
0
onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
123104
onvo Stockholders Equity During Period Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodIssuanceOfCommonStockFromWarrantExercises
30186
CY2016Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
160000
CY2015Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
0
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
160000
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
38234
CY2016Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
206266
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2060
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
206266
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27563
CY2016Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
206266
CY2015Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2060
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
206266
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
27563
CY2016Q3 onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
0
CY2015Q3 onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
100692
onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
2259
onvo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Upon Return Of Common Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUponReturnOfCommonShares
102951
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9614627
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1803140
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
56955
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11154546
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6347222
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.79
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.42
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.68
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.59
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1927137
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
328691
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7439063
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6054006
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M16D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M16D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7228
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7426
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7204
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7425
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0107
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0148
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0110
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0160
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.57
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.70
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
13580000
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
145000
CY2014Q4 onvo Class Of Warrant Or Right Life
ClassOfWarrantOrRightLife
P5Y
CY2014Q4 onvo Warrant Earning Period Through Issuance Of Common Stock
WarrantEarningPeriodThroughIssuanceOfCommonStock
P17M
onvo Number Of Warrant Shares Vested Upon Satisfaction Of Specific Performance Metrics
NumberOfWarrantSharesVestedUponSatisfactionOfSpecificPerformanceMetrics
95000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.734
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0121
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 onvo Number Of Non Cancelable Leases
NumberOfNonCancelableLeases
3
onvo Operating Leases Monthly Rent Expense
OperatingLeasesMonthlyRentExpense
83000
CY2016Q3 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03
onvo Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
30895
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2021-09-01
onvo Lease Option Termination Description
LeaseOptionTerminationDescription
option to terminate on or after September 1, 2019
onvo Additional Office Space
AdditionalOfficeSpace
14700
CY2015Q1 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
5803
CY2015Q1 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P36M
CY2015Q1 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03
CY2015Q4 onvo Additional Leased Office Space
AdditionalLeasedOfficeSpace
12088
CY2015Q4 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P12M
CY2015Q4 onvo Lease Rental Period Start Date
LeaseRentalPeriodStartDate
2016-02-01
CY2015Q4 onvo Lease Rental Period End Date
LeaseRentalPeriodEndDate
2017-01-31
CY2015Q4 onvo Operating Leases Monthly Base Rent Expense
OperatingLeasesMonthlyBaseRentExpense
15000
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
302000
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
272000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
642000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1148000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1044000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1072000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1104000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
468000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5478000

Files In Submission

Name View Source Status
0001564590-16-027345-index-headers.html Edgar Link pending
0001564590-16-027345-index.html Edgar Link pending
0001564590-16-027345.txt Edgar Link pending
0001564590-16-027345-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
onvo-10q_20160930.htm Edgar Link pending
onvo-20160930.xml Edgar Link completed
onvo-20160930.xsd Edgar Link pending
onvo-20160930_cal.xml Edgar Link unprocessable
onvo-20160930_def.xml Edgar Link unprocessable
onvo-20160930_lab.xml Edgar Link unprocessable
onvo-20160930_pre.xml Edgar Link unprocessable
onvo-ex311_9.htm Edgar Link pending
onvo-ex312_66.htm Edgar Link pending
onvo-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending